Was Policy Fellow for House Oversight and Government Reform Committee
Greg Walden, partner at McGuireWoods and senior advisor with McGuireWoods Consulting, recently discussed legal concerns, ethical considerations and policy around autonomous vehicles with the Corporate Counsel Business Journal.
In a Sept. 10 opinion piece for The Hill, McGuireWoods Consulting executive vice president and director, Frank Donatelli, compares the upcoming midterm elections and modern politics to a heavyweight fight.
Former Educator Touts Strong Legislative Affairs Background
Client Service, Business Growth Remain Top Priority
Your weekly North Carolina political news report.
This Week: Opioid legislation moves; Shutdown averted for now; CMS Encourages State Work Requirements in Medicaid
The General Assembly will reconvene for a special session on Tuesday, October 2nd at 10 AM. Lawmakers will be taking up issues to address disaster relief. School calendars, teacher pay, and delays in small business tax deadlines will be up for discussion. The session could then be adjourned until October 9th to address any further funding needs and pending executive agency reports.
This Week: Congress, Administration Seek Input on Approaches to Consumer Data Privacy | Compromise FAA Reauthorization Bill Directs US Drone and Transportation Security Technology Policy | FTC Holds Second Hearing on Competition and Consumer Protection in the 21st Century
In 2018, the Romanian Parliament set the scene for future offshore investments in the Black Sea by passing a bill to regulate the offshore legislative framework. Currently, the legislative process is ongoing and Parliament is reevaluating some provisions at the request of the Romanian President.
An overview of the upcoming week in Congress from the McGuireWoods Consulting Federal Public Affairs Team.
The Centers for Medicare and Medicaid Services (CMS) recently proposed to expand its site-neutral payment policy to clinic visits.
The House of Representatives approved the first major change to federal regulation of the over-the-counter drug industry in 40 years.